CARMA FUND

CARMA FUND

Munich, Bavariacarma-fund.com

Overview

CARMA FUND I is an early-stage investment fund for advancing Life Science and Healthcare technologies. The fund started off with a First Closing in June 2022 and has €50M under management. It is based in Munich and Frankfurt am Main. The fund invests in opportunities from the Life Science and Healthcare sector, including R&D tools, platform technologies, improvements to the healthcare system or technologies from the white or green biotech sector.

Year Founded

2022

Portfolio Companies

11

Investments

CompanyDateStageLead
KupandoMar 2026Series A ExtensionCo-investor
Exciva GmbHJan 2026Series BCo-investor
TECregenJan 2026SeedCo-investor
WMT AGOct 2025VC RoundCo-investor
Akribion TherapeuticsFeb 2025SeedLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMunich, Bavaria
Year Founded2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.